Institutions profited after Brii Biosciences Limiteds market cap rose HK109m last week but individual investors profited the most - Simply Wall St
BRIBF Stock | USD 0.13 0.00 0.00% |
Roughly 56% of Brii Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Brii Biosciences Limited pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Brii Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Brii Biosciences stock news signals to limit their universe of possible portfolio assets.
Brii Biosciences pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Brii daily returns and investor perception about the current price of Brii Biosciences Limited as well as its diversification or hedging effects on your existing portfolios.
Brii |
Institutions profited after Brii Biosciences Limiteds market cap rose HK109m last week but individual investors profited the most Simply Wall St
Read at news.google.com
Brii Biosciences Fundamental Analysis
We analyze Brii Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brii Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brii Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Brii Biosciences is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Brii Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brii Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Brii Biosciences could also be used in its relative valuation, which is a method of valuing Brii Biosciences by comparing valuation metrics with similar companies.
Peers
Brii Biosciences Related Equities
AVTX | Avalo Therapeutics | 15.02 | ||||
INZY | Inozyme Pharma | 12.12 | ||||
ZVSA | ZyVersa Therapeutics | 7.86 | ||||
HOOK | Hookipa Pharma | 7.84 | ||||
SONN | Sonnet Biotherapeutics | 7.60 | ||||
ETNB | 89bio | 3.18 | ||||
MIRM | Mirum Pharmaceuticals | 3.06 | ||||
AXSM | Axsome Therapeutics | 1.58 | ||||
INCY | Incyte | 1.05 | ||||
SRPT | Sarepta Therapeutics | 0.70 | ||||
BNTC | Benitec Biopharma | 0.28 | ||||
AKRO | Akero Therapeutics | 0.00 | ||||
DAWN | Day One | 0.80 | ||||
TERN | Terns Pharmaceuticals | 0.86 | ||||
ACAD | ACADIA Pharmaceuticals | 1.31 | ||||
CABA | Cabaletta Bio | 2.31 | ||||
ALZN | Alzamend Neuro | 2.54 | ||||
VRAX | Virax Biolabs | 3.27 | ||||
XFOR | X4 Pharmaceuticals | 8.52 | ||||
CDIO | Cardio Diagnostics | 11.00 |
Complementary Tools for Brii Pink Sheet analysis
When running Brii Biosciences' price analysis, check to measure Brii Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brii Biosciences is operating at the current time. Most of Brii Biosciences' value examination focuses on studying past and present price action to predict the probability of Brii Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brii Biosciences' price. Additionally, you may evaluate how the addition of Brii Biosciences to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |